Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aprepitant for Aldosterone Secretion in Obstructive Sleep Apnea and Hypertension
NCT06462287Phase 2Recruiting
- Sponsor
- Rouen University Hospital
- Start
- Mar 2024
- Primary completion
- Jun 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of aprepitant in obstructive sleep apnea syndrome (OSAS), essential hypertension, sponsored by Rouen University Hospital. Started Mar 2024; status: recruiting.
02
Drugs
aprepitant
03
Conditions
obstructive sleep apnea syndrome (OSAS)essential hypertension
Beyond the preview
Go deeper on NCT06462287.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06462287.